Kerr, Wesley T.
McFarlane, Katherine N.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R25 NS089450)
American Academy of Neurology (Susan S. Spencer Clinical Research Training Scholarship, Susan S. Spencer Clinical Research Training Scholarship)
Epilepsy Study Consortium (Epilepsy Foundation Mini-Grant)
Article History
Accepted: 24 October 2023
First Online: 7 December 2023
Declarations
:
: Dr. Kerr writes review articles for Medlink Neurology; has paid consulting agreements with SK Life Science, Janssen, Biohaven Pharmaceutical, and Radius Health; and has unpaid research agreements with UCB, GSK, Johnson & Johnson, Eisai, and Jazz Pharmaceuticals. These companies had no part in the production of this manuscript. Ms. McFarlane has no relevant disclosures.
: This article does not contain data from any new studies with human or animal subjects performed by the any of the authors.